alpha-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease. - Wikidata - wikimedia - TriplyDB

alpha-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease.

alpha-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease.

http://www.wikidata.org/entity/Q35098434

about

Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease Dysfunctions of neuronal and glial intermediate filaments in disease Signaling mechanisms and disrupted cytoskeleton in the diphenyl ditelluride neurotoxicity Progranulin and frontotemporal lobar degeneration Selective functional, regional, and neuronal vulnerability in frontotemporal dementia Neuronal intranuclear inclusions are ultrastructurally and immunologically distinct from cytoplasmic inclusions of neuronal intermediate filament inclusion disease Segmental axonopathy of Merino sheep in New Zealand.Neuropathological heterogeneity in frontotemporal lobar degeneration with TDP-43 proteinopathy: a quantitative study of 94 cases using principal components analysis FUS immunogold labeling TEM analysis of the neuronal cytoplasmic inclusions of neuronal intermediate filament inclusion disease: a frontotemporal lobar degeneration with FUS proteinopathy.Distinct pathological subtypes of FTLD-FUS.Brain biopsy in dementia: clinical indications and diagnostic approach.Suppression of extensive neurofilament phosphorylation rescues α-Internexin/peripherin-overexpressing PC12 cells from neuronal cell death.The cytoskeleton in neurodegenerative diseases.A morphometric study of the spatial patterns of TDP-43 immunoreactive neuronal inclusions in frontotemporal lobar degeneration (FTLD) with progranulin (GRN) mutation.The spectrum and severity of FUS-immunoreactive inclusions in the frontal and temporal lobes of ten cases of neuronal intermediate filament inclusion disease.Abnormalities of the nucleus and nuclear inclusions in neurodegenerative disease: a work in progress.A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies Spatial patterns of FUS-immunoreactive neuronal cytoplasmic inclusions (NCI) in neuronal intermediate filament inclusion disease (NIFID).Integrated analyses of zebrafish miRNA and mRNA expression profiles identify miR-29b and miR-223 as potential regulators of optic nerve regeneration.Neurofilament subunits are integral components of synapses and modulate neurotransmission and behavior in vivo.Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease Spatial patterns of TDP-43 neuronal cytoplasmic inclusions (NCI) in fifteen cases of frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP).Peripherin is a subunit of peripheral nerve neurofilaments: implications for differential vulnerability of CNS and peripheral nervous system axons.Keratin 8 overexpression promotes mouse Mallory body formation.alpha-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseases Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis.Modest loss of peripheral axons, muscle atrophy and formation of brain inclusions in mice with targeted deletion of gigaxonin exon 1 The many ways to frontotemporal degeneration and beyond.Frontotemporal dementia: clinicopathological correlations Frontotemporal dementia and related disorders: deciphering the enigma.A truncating SOD1 mutation, p.Gly141X, is associated with clinical and pathologic heterogeneity, including frontotemporal lobar degeneration Different molecular pathologies result in similar spatial patterns of cellular inclusions in neurodegenerative disease: a comparative study of eight disorders The molecular basis of frontotemporal dementia.Review: Recent progress in frontotemporal lobar degeneration.Novel types of frontotemporal lobar degeneration: beyond tau and TDP-43.Neuropathological background of phenotypical variability in frontotemporal dementia.Basophilic inclusions and neuronal intermediate filament inclusions in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.Gene expression analysis of frontotemporal lobar degeneration of the motor neuron disease type with ubiquitinated inclusions.Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype.Clinicopathological and genetic correlates of frontotemporal lobar degeneration and corticobasal degeneration.

P2860

Q24628685-02F76660-D62B-4398-BFEA-DDB719E92C88 Q24657653-AF599CE9-7C96-49F4-B757-928661F86ED8 Q27026946-C6266768-D799-4F00-98E6-4A91CD0C3FC3 Q28306543-F3DBA533-1988-4866-8E0A-3607349D5E99 Q28750210-C8B1718F-46F5-4257-8256-8BD637BB7C11 Q33219725-80B2228B-B7AC-4D0A-9F93-3612C7311048 Q33259744-786EA840-21DE-484A-B64C-4137C23605DD Q33694019-4981D59B-FF8E-482A-AF18-9A2B03C0B905 Q33908722-74C57484-021D-405E-8598-0542396B4E2F Q34024578-17CA2453-26ED-44A3-8856-9F74D2504FEB Q34126719-D2A28C7E-FB8D-42B9-8FA1-5E5BFB85ED84 Q34405787-DEE6BFB7-9882-4B92-9C9D-9829239B70C8 Q34446779-D6150BF7-0BD6-4111-BA4F-C82BA2F090CE Q34473037-B92F154F-E5D9-4AC1-B1A0-9CF9454BCA35 Q34557808-6F32CB53-F30D-44A4-BFEA-88F28A0304E2 Q34604521-E9FA7BFB-6FA8-48C9-981D-0017A5D95B7F Q35206942-E8E03AE7-3499-4CBB-869E-C2400658937E Q35421505-DC21611F-43A3-44D6-8185-C0165847E0E6 Q35743261-6EEA7AA3-6092-4E5A-86D5-D91D726CB01F Q35888052-8376BF03-17C3-4949-99FD-76151FF17D31 Q35927831-8B2CD854-934C-4B05-A903-122787F4ED0B Q36047031-E35FA927-C9BC-4597-BF0F-A21EFA42CC40 Q36118475-378B952C-E27C-475B-A74C-B2A749EAE002 Q36320550-25431819-D037-48C5-94DC-A1A93DABFB98 Q36452247-96BDF618-3268-4D06-9147-0EF05BC089EC Q36459963-6CDCABE0-5842-42AE-9D67-D719110A27BE Q36853945-4944F825-13AA-4E96-ADCA-28F932DB9FEE Q36986572-B3E94C98-0BF8-4A33-90CB-5D757E19533E Q37069848-8420ECEC-3CDA-41B6-AF5E-CFE92AE029B9 Q37231124-756FB2D0-73D8-4D5E-9578-BE3F50FB19B2 Q37289759-A3690957-C4BB-4DFE-B210-D9DD2A262BD8 Q37392690-D855A2D7-271A-4969-94AD-B41F63918EAB Q37564674-793EB950-8A29-4C6E-B1EB-0D8F2EB82002 Q37613084-26653152-B007-4B5C-93BA-BC8695692339 Q37878394-2D25C3F9-A932-426D-A1A8-206CE9C32359 Q37879961-D3B2118F-8054-4917-903D-AB2523ECB2CC Q38199745-7097216C-970B-4A18-9139-7305F02ECD45 Q38300822-2699B988-E23D-46E0-B568-24F58EC3DCAC Q38382217-008E3446-84CD-4227-96F8-4ACA771FF7F8 Q38391502-785369D6-000D-4411-92A5-46B1C7917129

P2860

alpha-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease.

http://www.wikidata.org/entity/Q35098434

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

alpha-internexin is present in ...... te filament inclusion disease.

@ast

alpha-internexin is present in ...... te filament inclusion disease.

@en

type

label

alpha-internexin is present in ...... te filament inclusion disease.

@ast

alpha-internexin is present in ...... te filament inclusion disease.

@en

prefLabel

alpha-internexin is present in ...... te filament inclusion disease.

@ast

alpha-internexin is present in ...... te filament inclusion disease.

@en

P1433

Q35098434-0D006A2F-A7A3-4BAE-A556-45449B5F2898

P1476

Q35098434-C8D6254E-DBB0-43B1-8C3F-96EFDD793E4B

P2093

Q35098434-13E35569-D1A2-49C7-ADD7-E317B16E29F3

Q35098434-1436ADBC-F444-4B46-AF8C-21FCAEFC9196

Q35098434-19AC2BF4-6B81-480A-8698-B0A7389067F9

Q35098434-2989112E-1481-406F-9F8C-6841947AD8BD

Q35098434-535ABB81-AF29-4FB0-B0D5-153845400218

Q35098434-725CB1E6-E4CF-446E-9C08-81A5FD1661C5

Q35098434-BA2F0FC8-4E8E-490F-A9B2-3669CF9C619C

Q35098434-C7028E5C-5C97-460C-BC3A-7C7D19BEBAC1

Q35098434-C8E7062E-4F9A-40C6-AA85-A5C4284F1DD2

Q35098434-DBBF7D25-EA89-4914-8186-30750F9197E1

P2860

Q35098434-07B91E1D-6BB4-4D98-8267-1262C0103D8C

Q35098434-220C0828-E43E-4786-B0A5-94F5B58231D3

Q35098434-2D6EC342-D72F-4BFC-8B0F-E383ABB25257

Q35098434-37358212-F532-4290-852C-B45BD86D2980

Q35098434-417B2D1C-22B7-4322-A6CF-C63367DD9BA2

Q35098434-433FC93E-0FD3-4B71-8FA6-D628DCC6B855

Q35098434-5A24C291-D7EE-4964-A4AB-A84ED7DE2D75

Q35098434-5BE9CB2A-39BF-4EB0-8629-EC2CBBABFEFE

Q35098434-5C13B68C-023B-4506-9B29-D7999C644625

Q35098434-6334809A-5E63-4AB6-ABA6-3098BD610B81

P304

Q35098434-4F0E80CC-24D5-4B5C-AB52-EC5C76357EBC

P31

Q35098434-19607D61-D214-43ED-8C36-0B7C82AE7F25

P356

Q35098434-BE33E544-EC2F-4D53-ACB1-038CB14FF10E

P407

Q35098434-0CDB0CE5-8E07-4255-8794-155244EC74BD

P433

Q35098434-D2AE657E-83B4-4007-9057-A658A38B8D2A

P478

Q35098434-A152A614-35BB-4E8E-8DB6-95DC681E04BE

P50

Q35098434-F5EECD38-0E84-483A-A3BC-F667B922331B

P577

Q35098434-6742368F-5955-4FA2-B259-326629BFFCA2

P698

Q35098434-EB2D6D85-DBD6-47AC-9D02-BF462BA80437

P932

Q35098434-5C5BBF4A-1C25-4432-B6C4-3336FC9EB005

P356

S0002-9440(10)63773-X

P1433

The American Journal of Pathology

P1476

alpha-internexin is present in ...... te filament inclusion disease.

@en

P2093

Bin Zhang

http://www.w3.org/2001/XMLSchema#string

Charles Duyckaerts

http://www.w3.org/2001/XMLSchema#string

Eileen Bigio

http://www.w3.org/2001/XMLSchema#string

Evelyn Jaros

http://www.w3.org/2001/XMLSchema#string

Hideaki Yokoo

http://www.w3.org/2001/XMLSchema#string

Ian R A Mackenzie

http://www.w3.org/2001/XMLSchema#string

Kunihiro Uryu

http://www.w3.org/2001/XMLSchema#string

Marla Gearing

http://www.w3.org/2001/XMLSchema#string

Nigel J Cairns

http://www.w3.org/2001/XMLSchema#string

Robert H Perry

http://www.w3.org/2001/XMLSchema#string

P2860

Neurodegenerative tauopathies

Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia.

Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies.

From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases.

Update on the neuropathological diagnosis of frontotemporal dementias.

Phosphate dependent and independent neurofilament epitopes in the axonal swellings of patients with motor neuron disease and controls.

Neurofilaments and neurological disease.

Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis.

Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ.

Roles of head and tail domains in alpha-internexin's self-assembly and coassembly with the neurofilament triplet proteins.

P304

2153-2161

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)63773-X

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

164

http://www.w3.org/2001/XMLSchema#string

P50

John Q. Trojanowski

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15161649

http://www.w3.org/2001/XMLSchema#string

P932

1615782

http://www.w3.org/2001/XMLSchema#string